Associations between psoriasis and mental illness : an update for clinicians
Copyright © 2022 Elsevier Inc. All rights reserved..
OBJECTIVE: This review explores the association between psoriasis and mental illness and the potential underlying pathophysiologic explanations for this association.
METHOD: Using a search via the MEDLINE database in December 2020, eligible studies with a focus on systematic reviews, meta-analyses, and randomized control trials (RCTs) were retrieved and reviewed.
RESULTS: Psoriasis patients are 1.5 times more likely to show depressive symptoms and experience a higher prevalence of anxiety symptoms (20-50%) than individuals without psoriasis. Schizophrenia (2.82%) and suicidal ideation (12.7%) are found to be more prevalent among psoriasis patients than among the general population. Pro-inflammatory markers, which play an important role in the pathophysiology of psoriasis, have been shown to be elevated in patients with depression, anxiety, and schizophrenia; this suggests shared inflammatory pathways may be involved.
CONCLUSIONS: There is an elevated burden of psychiatric co-morbidity in psoriasis patients which may be explained by an inflammatory model. We recommend that clinicians conduct universal screening of depression, anxiety, and suicidality among their psoriasis patients and remain vigilant for any symptoms of severe psychiatric conditions such as schizophrenia. Collaboration between dermatologists, psychiatrists and primary care physicians is essential in supporting psychological wellbeing and clinical outcomes for psoriasis patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
---|---|
Enthalten in: |
General hospital psychiatry - 75(2022) vom: 30. März, Seite 30-37 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hedemann, Thea L [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anxiety |
---|
Anmerkungen: |
Date Completed 17.03.2022 Date Revised 17.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.genhosppsych.2022.01.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336355106 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336355106 | ||
003 | DE-627 | ||
005 | 20231225231945.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.genhosppsych.2022.01.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n1121.xml |
035 | |a (DE-627)NLM336355106 | ||
035 | |a (NLM)35101785 | ||
035 | |a (PII)S0163-8343(22)00005-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hedemann, Thea L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Associations between psoriasis and mental illness |b an update for clinicians |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.03.2022 | ||
500 | |a Date Revised 17.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
520 | |a OBJECTIVE: This review explores the association between psoriasis and mental illness and the potential underlying pathophysiologic explanations for this association | ||
520 | |a METHOD: Using a search via the MEDLINE database in December 2020, eligible studies with a focus on systematic reviews, meta-analyses, and randomized control trials (RCTs) were retrieved and reviewed | ||
520 | |a RESULTS: Psoriasis patients are 1.5 times more likely to show depressive symptoms and experience a higher prevalence of anxiety symptoms (20-50%) than individuals without psoriasis. Schizophrenia (2.82%) and suicidal ideation (12.7%) are found to be more prevalent among psoriasis patients than among the general population. Pro-inflammatory markers, which play an important role in the pathophysiology of psoriasis, have been shown to be elevated in patients with depression, anxiety, and schizophrenia; this suggests shared inflammatory pathways may be involved | ||
520 | |a CONCLUSIONS: There is an elevated burden of psychiatric co-morbidity in psoriasis patients which may be explained by an inflammatory model. We recommend that clinicians conduct universal screening of depression, anxiety, and suicidality among their psoriasis patients and remain vigilant for any symptoms of severe psychiatric conditions such as schizophrenia. Collaboration between dermatologists, psychiatrists and primary care physicians is essential in supporting psychological wellbeing and clinical outcomes for psoriasis patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a Anxiety | |
650 | 4 | |a Bipolar disorder | |
650 | 4 | |a Depression | |
650 | 4 | |a Mental illness | |
650 | 4 | |a Psoriasis | |
650 | 4 | |a Schizophrenia | |
700 | 1 | |a Liu, Xinran |e verfasserin |4 aut | |
700 | 1 | |a Kang, Cindy N |e verfasserin |4 aut | |
700 | 1 | |a Husain, Muhammad I |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t General hospital psychiatry |d 1987 |g 75(2022) vom: 30. März, Seite 30-37 |w (DE-627)NLM000421065 |x 1873-7714 |7 nnns |
773 | 1 | 8 | |g volume:75 |g year:2022 |g day:30 |g month:03 |g pages:30-37 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.genhosppsych.2022.01.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 75 |j 2022 |b 30 |c 03 |h 30-37 |